Tobramycin Exposure From Active Calcium Sulfate Bone Graft Substitute
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study aimed to assess the systemic absorption and disposition of tobramycin in patients
treated with a tobramycin-laden bone graft substitute (Osteoset® T).